Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 3,156 | 8,412 | 1,514 | 1,917 | 1,362 |
| Gross Profit | 3,156 | 8,412 | 1,514 | 1,917 | 1,362 |
| Operating Expenses | 5,321 | 4,631 | 6,006 | 5,220 | 2,807 |
| Operating Income | -2,165 | 3,781 | -4,492 | -3,303 | -1,445 |
| Interest Expense | 0 | -47 | 1 | 63 | 178 |
| Other Income | 47 | 216 | 2 | 150 | 0 |
| Pre-tax Income | -2,118 | 4,044 | -4,491 | -3,216 | -1,622 |
| Income Tax | -162 | 299 | 54 | 148 | 6 |
| Net Income Continuous | -1,957 | 3,744 | -4,544 | -3,363 | -1,629 |
| Net Income Discontinuous | N/A | N/A | N/A | 2,612 | 332 |
| Net Income | $-1,957 | $3,744 | $-4,544 | $-751 | $-1,297 |
| EPS Basic Total Ops | -0.32 | 0.64 | -0.86 | -0.14 | -0.26 |
| EPS Basic Continuous Ops | -0.32 | 0.64 | -0.86 | -0.64 | -0.33 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.50 | 0.07 |
| EPS Diluted Total Ops | -0.32 | 0.55 | -0.86 | -0.14 | -0.26 |
| EPS Diluted Continuous Ops | -0.32 | 0.55 | -0.86 | -0.64 | -0.33 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.50 | 0.07 |
| EBITDA(a) | $-2,129 | $3,837 | $-4,459 | $-3,053 | $-1,248 |